| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |